Cargando…

IBD metabonomics predicts phenotype, disease course, and treatment response

Metabonomics in inflammatory bowel disease (IBD) characterizes the effector molecules of biological systems and thus aims to describe the molecular phenotype, generate insight into the pathology, and predict disease course and response to treatment. Nuclear magnetic resonance (NMR) spectroscopy, mas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bjerrum, Jacob T., Wang, Yulan L., Seidelin, Jakob B., Nielsen, Ole H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379620/ https://www.ncbi.nlm.nih.gov/pubmed/34419930 http://dx.doi.org/10.1016/j.ebiom.2021.103551

Ejemplares similares

Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2013)

Metabonomics in Gastroenterology and Hepatology
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2019)

Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2014)

Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD
por: Soendergaard, Christoffer, et al.
Publicado: (2018)

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2017)

Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2022)

Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study
por: Zhao, Mirabella, et al.
Publicado: (2020)

Impact of T300A Variant of ATG16L1 on Antibacterial Response, Risk of Culture Positive Infections, and Clinical Course of Crohn's Disease
por: Salem, Mohammad, et al.
Publicado: (2015)

Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer
por: Tian, Yuan, et al.
Publicado: (2016)

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
por: Attauabi, Mohamed, et al.
Publicado: (2022)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Mwinyi, Jessica, et al.
Publicado: (2012)

Evidence for Impaired CARD15 Signalling in Crohn's Disease without Disease Linked Variants
por: Seidelin, Jakob Benedict, et al.
Publicado: (2009)

Integrative metabonomics as potential method for diagnosis of thyroid malignancy
por: Tian, Yuan, et al.
Publicado: (2015)

Identification of TNF-α-Responsive Promoters and Enhancers in the Intestinal Epithelial Cell Model Caco-2
por: Boyd, Mette, et al.
Publicado: (2014)

Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease
por: Holmberg, Fredrik EO, et al.
Publicado: (2017)

Metabonomic Investigation of Single and Multiple Strain Trypanosoma brucei brucei Infections
por: Li, Jia V., et al.
Publicado: (2011)

Metabonomics Research Progress on Liver Diseases
por: Yu, Mengqian, et al.
Publicado: (2017)

Tumor growth affects the metabonomic phenotypes of multiple mouse non-involved organs in an A549 lung cancer xenograft model
por: Xu, Shan, et al.
Publicado: (2016)

Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review
por: Wang, Yang, et al.
Publicado: (2021)

Metabonomics in toxicity assessment /
Publicado: (2005)

Clinical and Epidemiological Metabonomics
por: Ala-Korpela, Mika, et al.
Publicado: (2011)

Metabonomics and intensive care
por: Antcliffe, David, et al.
Publicado: (2016)

Difference in Intestinal Flora and Characteristics of Plasma Metabonomics in Pneumoconiosis Patients
por: Li, Yingdi, et al.
Publicado: (2022)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Correlations of Fecal Metabonomic and Microbiomic Changes Induced by High-fat Diet in the Pre-Obesity State
por: Lin, Hong, et al.
Publicado: (2016)

Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report
por: Holmstroem, Rikke Boedker, et al.
Publicado: (2022)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
por: Singh, Arshdeep, et al.
Publicado: (2023)

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review
por: Nielsen, Ole Haagen, et al.
Publicado: (2013)

Identification of Morphine and Heroin-Treatment in Mice Using Metabonomics
por: Lu, Wuhuan, et al.
Publicado: (2021)

Metabonomics: Mining for Metabolites in Biofluids
Publicado: (2002)

Metabonomics window into plateau hypoxia
por: Chang, Yue, et al.
Publicado: (2019)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2009)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
por: Bon, Lorenz, et al.
Publicado: (2019)

The Response of Volvariella volvacea to Low-Temperature Stress Based on Metabonomics
por: Zhao, Xu, et al.
Publicado: (2020)

Predicting Colorectal Cancer Occurrence in IBD
por: Yalchin, Mehmet, et al.
Publicado: (2021)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
por: Atreya, Raja, et al.
Publicado: (2020)

Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
por: Attauabi, Mohamed, et al.
Publicado: (2023)

Metabonomic Profile and Signaling Pathway Prediction of Depression-Associated Suicidal Behavior
por: Liu, Song
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uqfap3ier9adf581pkk3j2m2p6